Noninvasive prenatal screening (NICC) is a technique that allows us to detect trisomies in the foetus using fetal DNA in the mother’s blood by means of a simple maternal blood test. Trisomies can be detected in the foetus of the following chromosomes 13,18, 21, X and Y. Free DNA of foetal origin is isolated and through latest generation bioinformatic techniques study these chromosomes.

Thanks to this technique, foetal diseases such as Down Syndrome can be detected early and safe for the mother. It can be performed in twin pregnancies and also in gestations originating with egg donation. The sex of the fetus is also disclosed.

This analysis can be performed from the 10th week of gestation and the results are

obtained in approximately 15 days.